Endothelial progenitor cells as a therapeutic option in intracerebral hemorrhage
Intracerebral hemorrhage (ICH) is the most severe cerebrovascular disease, which represents a leading cause of death and disability in developed countries. However, therapeutic options are limited, so is mandatory to investigate repairing processes after stroke in order to develop new therapeutic st...
Main Authors: | Juan Pías-Peleteiro, Francisco Campos, José Castillo, Tomás Sobrino |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Neural Regeneration Research |
Subjects: | |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2017;volume=12;issue=4;spage=558;epage=561;aulast=Pías-Peleteiro |
Similar Items
-
The Therapeutic Value of Bone Marrow-Derived Endothelial Progenitor Cell Transplantation after Intracerebral Hemorrhage in Rats
by: Yuming Xu, et al.
Published: (2017-05-01) -
Therapeutic effects of exosomes from angiotensin-converting enzyme 2 -overexpressed endothelial progenitor cells on intracerebral hemorrhagic stroke
by: Jinju Wang, et al.
Published: (2021-03-01) -
Location and volume of intracerebral hemorrhage and their association with outcome
by: Venkateswara Rao Tangella, et al.
Published: (2020-01-01) -
The Effect of Telemedicine Consultation on Outcomes in Patients with Intracerebral Hemorrhage
by: A. M. Alasheyev, et al.
Published: (2020-01-01) -
Treatment of 817 patients with spontaneous supratentorial intracerebral hemorrhage: characteristics, predictive factors and outcome
by: Homajoun Maslehaty, et al.
Published: (2012-05-01)